Investor Database / OrbiMed

OrbiMed

Fund Type

Venture Fund

Founding Year

1989

About

OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.

Stages

Seed, Series A, Series B, Series C, Series D

Investments

562

Geography

New York

Exits

212

Sectors

BioTechMedical DevicePharmaceuticalsHealthcareHR TechFemTechHealth & WellnessLife ScienceArtificial Intelligence & Machine Learning (AI/ML)SoftwareFood and BeverageMobile

Portfolio Companies

Aspen NeuroscienceCarrot FertilitySionna TherapeuticsGentiBioXtalPiReCode TherapeuticsScribe TherapeuticsEntosQ32 BioACELYRINCyrus BiotechnologyiECUREGennao BioEnliven TherapeuticsArriVent BiopharmaCrown BiosciencePionyr ImmunotherapeuticsOdyssey TherapeuticsAdicet BioBinx HealthTurnstone BiologicsElectra Therapeutics